Cardiac molecular imaging is a cutting-edge field that employs advanced imaging techniques to delve into the molecular processes occurring within the heart. This sophisticated approach allows for a detailed examination of cellular and molecular activities, enabling a deeper understanding of cardiac conditions at the molecular level. By utilizing targeted imaging agents, researchers can visualize and analyze specific molecular markers associated with cardiovascular diseases, paving the way for early detection, precise diagnosis, and personalized treatment strategies. Cardiac molecular imaging holds immense promise in revolutionizing our approach to cardiovascular health by providing insights into the intricate molecular mechanisms underlying heart diseases, ultimately contributing to more effective interventions and improved patient outcomes.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain